Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Pharmacol.

Sec. Pharmacology of Anti-Cancer Drugs

Volume 16 - 2025 | doi: 10.3389/fphar.2025.1564199

This article is part of the Research TopicExploiting Biomarkers for Targeted Therapies in Acute Myeloid LeukemiaView all 3 articles

L1, a 3,3'-Diindolylmethane-derivative, induced ER stress-mediated apoptosis and suppressed growth through the FLI1/AKT pathway in erythroleukemia HEL cells

Provisionally accepted
Yi  KuangYi Kuang1Yong  JianYong Jian1Dinghuan  WangDinghuan Wang1Lihao  BaiLihao Bai1Kunlin  YuKunlin Yu1WANG  CHUNLINWANG CHUNLIN1Wuling  LiuWuling Liu1Sheng  LiuSheng Liu1Wan  LiWan Li2*Yaacov  Ben-DavidYaacov Ben-David1*Xiao  XiaoXiao Xiao1*
  • 1Guizhou Medical University, Guiyang, China
  • 2Chinese Academy of Medical Sciences and Peking Union Medical College, Dongcheng, Beijing Municipality, China

The final, formatted version of the article will be published soon.

Introduction: 3,3’-Diindolylmethane (DIM) is a major phytochemical product derived from ingestion of cruciferous vegetables. As an effective cancer chemopreventive agent, DIM has been used in preclinical and clinical trials. Recently, our group synthesized and modified a novel DIM derivative, L1, and demonstrated its significant antileukemic activities. Methods: MTT assay was used to confirm the inhibition rates and IC50 value of L1 in erythroleukemia HEL cells. Flow cytometry analysis was used to reveal cell cycle arrest and apoptosis. RNAseq data with KEGG pathway enrichment analysis was performed to predict the anticancer mechanism of L1. RT-qPCR and Western blotting were carried out to verify the mechanism in the ER stress-mediated apoptosis and FLI1/AKT pathway. FLI1 knockdown in HEL cells was performed to confirm the mechanism of L1 in the FLI1/AKT pathway. AutoDocking analysis and PPI analysis via the STRING database were used to discover the potential target of L1. HSPA1A knockdown and treatment with HSP70 inhibitor were used to further evaluate the L1 target. Results: L1 significantly inhibited the growth of erythroleukemia HEL cells, with an IC50 value of 1.15±0.03 µM. L1 induced G2/M cell cycle arrest and cell apoptosis. RNA sequencing analysis revealed that differentially expressed genes (DEGs) mainly enriched in protein processing of endoplasmic reticulum (ER). L1 increased the protein expression level of GRP78 (BIP) and the RNA transcription of XBP1 and DDIT3 to induce ER stress-mediated apoptosis. Meanwhile, PPI analysis and AutoDocking analysis also revealed that L1 may bind to the HSP70 protein (HSPA1A and HSPA1B) . The apoptosis rate was reduced by cotreatment of L1 and the Hsp70 inhibitor VER155008.Moreover, the inhibition rate was decreased in the HSPA1A knockdown HEL cells, suggesting that L1-induced apoptosis was related to HSP70 activity. Moreover, we showed that the protein expression levels of FLI1 and AKT/p-AKT decreased with L1 treatment and that the RNA expressions of their downstream genes GATA1, TFRC, GYPA, CDKN1A and CDKN1B were also regulated by L1. Conclusion: This study revealed that the DIM-derivative molecule, L1, induced ER stress-mediated apoptosis and suppressed cell growth by inhibiting the FLI1/AKT pathway in erythroleukemia HEL cells.

Keywords: Erythroleukemia, 3,3'-diindoylmethane derivatives, endoplasmic reticulum stress-mediated apoptosis, FLI1, Hsp70

Received: 21 Jan 2025; Accepted: 09 Jul 2025.

Copyright: © 2025 Kuang, Jian, Wang, Bai, Yu, CHUNLIN, Liu, Liu, Li, Ben-David and Xiao. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Wan Li, Chinese Academy of Medical Sciences and Peking Union Medical College, Dongcheng, 100006, Beijing Municipality, China
Yaacov Ben-David, Guizhou Medical University, Guiyang, China
Xiao Xiao, Guizhou Medical University, Guiyang, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.